Dr. Kojo Elenitoba-Johnson, M.D. is the inaugural Peter C. Nowell, MD Professor at the Perelman School of Medicine at University of Pennsylvania. His is also the Founding Director of Penn Medicine’s Center for Personalized Diagnostics and the Founding Director of the Division of Precision and Computational Diagnostics. Dr. Elenitoba-Johnson is an international leader in the fields of Hematopathology, and Genomic Pathology, as well as mass spectrometry-driven proteomics.
Dr. Elenitoba-Johnson, MD earned his medical degree from the College of Medicine, University of Lagos, in Lagos, Nigeria. He completed his residency in anatomic and clinical pathology at Brown University School of Medicine, where he served as chief resident. He then moved on to the National Cancer Institute to complete a fellowship in hematopathology. Dr. Elenitoba-Johnson held faculty positions at the University of Utah and the University of Michigan where he held the Henry C. Bryant Professorship, and served as director of the Division of Translational Research. His research focuses on the pathogenesis of human malignant lymphomas, biomarker discovery by genomic and proteomic profiling and cancer. His research has earned support from the National Institutes of Health and private foundations. Dr. Elenitoba-Johnson has been recognized with numerous awards, including the Ramzi Cotran Outstanding Young Investigator Award from the United States and Canadian Academy of Pathology in 2006 and the Outstanding Investigator Award given by the American Society for Investigative Pathology (2012). He is an elected member of the American Society for Clinical Investigation (2011).
He is a member of the Board of Scientific Counselors for Clinical Sciences and Epidemiology for the National Cancer Institute and is currently the President-Elect of the Association for Molecular Pathology.
He has authored or co-authored more than 150 peer-reviewed articles and 40 chapters to professional textbooks in Pathology.